AlphaOS

Intelligence coverage: 65%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

IMCR

Immunocore Holdings plc

Healthcare · Biological Products, (No Diagnostic Substances)

$30.72Sep 25, 2026

AI confidence 70% · prior close shown (market closed)

Investment Snapshot

RiskMedium

3 signals not yet derived from pipeline evidence

Pipeline evidence · 78d ago

IMCR's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on IMCR.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest Intelligence

Updated

What happened recently for Immunocore Holdings plc (IMCR) — events, not interpretation.

Event
Last session September 25, 2026 at $30.72.
Source
Market data

Research & analysis only — not investment advice.

Building company intelligence…

Immunocore Holdings plc (IMCR)

Healthcare · Biological Products, (No Diagnostic Substances)

Investment Snapshot above is the primary AlphaOS analysis for Immunocore Holdings plc — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Sector:
Healthcare
Industry:
Biological Products, (No Diagnostic Substances)
Market cap:
$1.58B
Revenue:
$249.43M

IMCR earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow Immunocore Holdings plc through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Related stock research

Connected companies and research pages from the AlphaOS knowledge graph.